Orgenesis Inc. (NASDAQ:ORGS – Get Free Report)’s stock price was down 5.9% during mid-day trading on Friday . The stock traded as low as $0.51 and last traded at $0.52. Approximately 228,991 shares traded hands during mid-day trading, an increase of 29% from the average daily volume of 177,759 shares. The stock had previously closed at $0.55.
Orgenesis Stock Performance
The stock’s 50 day moving average price is $0.70 and its two-hundred day moving average price is $0.64.
Orgenesis (NASDAQ:ORGS – Get Free Report) last released its quarterly earnings results on Thursday, August 8th. The company reported ($0.23) earnings per share for the quarter. The company had revenue of $0.25 million during the quarter.
Orgenesis Company Profile
Orgenesis Inc, a biotech company, focuses on cell and gene therapies worldwide. It operates through two segments, Octomera and Therapies. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed cell based POCare therapies that are processed and produced under closed and automated POCare technology systems across a collaborative POCare network consisting of research institutes and hospitals.
See Also
- Five stocks we like better than Orgenesis
- Are Penny Stocks a Good Fit for Your Portfolio?
- 3 Stocks That Could Rise on European Bank Interest Rate Cuts
- Retail Stocks Investing, Explained
- Take Advantage of Village Farms Stock as Cannabis Market Evolves
- Using the MarketBeat Dividend Tax Calculator
- MarketBeat Week in Review – 9/16 – 9/20
Receive News & Ratings for Orgenesis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orgenesis and related companies with MarketBeat.com's FREE daily email newsletter.
